Export

ATC codes: C03CA01
EMLc
Indication
Heart failure ICD11 code: BD0Z
INN
Furosemide
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
The square box does not apply to the listing of furosemide on the EMLc
Formulations
Parenteral > General injections > IV: 10 mg per mL in 2 mL ampoule ; 10 mg per mL in 5 mL ampoule
Oral > Liquid: 20 mg per 5 mL (EMLc) ; 50 mg per 5 mL (EMLc)
Oral > Solid > tablet: 40 mg ; 20 mg
EML status history
First added in 2005 (TRS 933)
Changed in 2007 (TRS 950)
Changed in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
bumetanide (ATC codes: C03CA02)
torasemide (ATC codes: C03CA04)
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the addition of new strength formulations of furosemide (injection 10 mg/mL in 5 mL; tablet 20 mg (EML and EMLc); oral liquid 50 mg/5 mL (EMLc). The Committee also recommended the removal of furosemide 10 mg tablets from the EMLc.